November 5, 2018

Capital Square 1031, a sponsor of Delaware statutory trust investments, announced that CS1031 Diversified Dialysis Portfolio DST, comprised of nine medical office buildings in five states, has been fully subscribed by a total of 45 investors.

Each property in the portfolio is 100 percent leased to Fresenius Medical Care, the leading provider of dialysis services and products, on a long-term, net basis with annual CPI rental increases. Fresenius is listed on both the Frankfurt Stock Exchange and New York Stock Exchange, and reported revenues of approximately $20 billion in 2017.

“Capital Square is pleased to fully subscribe this offering of our largest DST portfolio to-date, which provides investors the opportunity to own an interest in a high quality, diversified medical real estate portfolio 100 percent leased to an investment-grade company,” said Louis Rogers, founder and chief executive officer of Capital Square 1031. “The investment benefits from its need-based use — dialysis is a necessary and recurring medical treatment for more than 2.5 million Fresenius patients worldwide.”

To view the full article, click here.